Selected outcome
Above 8%
90%
Above 8% · 90%
Stored quote · checking the venue
- Scheduled end
- Mar 31, 2027 ET
- Resolution source
- Fiscal.ai (opens in a new tab)
Price
Loading price history.
Markets
- Above 10%
Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?
55%
Open · ~$0 24h · ~$0 vol
Bid 50¢ · Ask 60¢
- Above 10.5%
Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?
41%
Open · ~$0 24h · ~$7 vol
Bid 36¢ · Ask 46¢
- Above 11%
Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?
31%
Open · ~$0 24h · ~$218 vol
Bid 26¢ · Ask 36¢
- Above 11.5%
Will Medtronic plc report Above 11.5% cardiovascular organic revenue growth in Q2 2027?
25%
Open · ~$0 24h · ~$193 vol
Bid 20¢ · Ask 30¢
- Above 12%
Will Medtronic plc report Above 12% cardiovascular organic revenue growth in Q2 2027?
20%
Open · ~$0 24h · ~$508 vol
Bid 15¢ · Ask 25¢
- Above 13%
Will Medtronic plc report Above 13% cardiovascular organic revenue growth in Q2 2027?
16%
Open · ~$0 24h · ~$140 vol
Bid 11¢ · Ask 21¢
- Above 14%
Will Medtronic plc report Above 14% cardiovascular organic revenue growth in Q2 2027?
6%
Open · ~$0 24h · ~$101 vol
Bid 2¢ · Ask 10¢
- Above 8%
Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?
90%
Open · ~$0 24h · ~$242 vol
Bid 85¢ · Ask 95¢
- Above 9%
Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?
75%
Open · ~$0 24h · ~$918 vol
Bid 70¢ · Ask 80¢
Event statistics
How this resolves
- Scheduled end
- Mar 31, 2027 ET
- Resolution source
- Trading
- Closed
- In review
- Resolved
Rules text
If Medtronic plc reports Above 8% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes.